Glucagon-like Peptide-1 Receptor Agonist Use May Reduce Disease Activity and Progression in Osteoarthritis and Inflammatory Arthritis

Orthopedic Clinics of North America · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles